[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Standard Biotools Inc (LAB)

Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Standard Biotools Inc 50 Milk Street 10th Floor Boston MA 02109 USA

www.standardbio.com Employees: 389 P: 650-266-6000 F: 650-871-7152

Sector:

Medical

Description:

Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 398,175
Enterprise Value, $K 277,315
Shares Outstanding, K 390,368
Float, K 299,959
% Float 76.84%
Short Interest, K 8,479
Short Float 2.17%
Days to Cover 2.38
Short Volume Ratio 0.70
% of Insider Shareholders 23.16%
% of Institutional Shareholders 53.74%

Financials:

Annual Sales, $ 85,330 K
Annual Net Income, $ -74,900 K
Last Quarter Sales, $ 3,220 K
Last Quarter Net Income, $ 19,280 K
EBIT, $ -110,250 K
EBITDA, $ -101,920 K

Growth:

1-Year Return -8.52%
3-Year Return -42.37%
5-Year Return -81.32%
5-Year Revenue Growth -38.23%
5-Year Earnings Growth 78.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.02 on 05/05/26
Next Earnings Date 08/10/26
Earnings Per Share ttm -0.12
EPS Growth vs. Prev Qtr -160.00%
EPS Growth vs. Prev Year 50.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payable Date 07/29/03
Dividend Payout Ratio 0.00%

LAB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -8.18%
Return-on-Assets % -6.43%
Profit Margin % -87.78%
Debt/Equity 0.00
Price/Sales 4.57
Price/Cash Flow N/A
Price/Book 0.70
Book Value/Share 1.10
Interest Coverage -3,222.33
60-Month Beta 1.32
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.